Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1045
-
Total 13F shares, excl. options
-
93M
-
Shares change
-
+1.18M
-
Total reported value, excl. options
-
$55B
-
Value change
-
+$641M
-
Put/Call ratio
-
1.45
-
Number of buys
-
448
-
Number of sells
-
-515
-
Price
-
$591.13
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2022
1,218 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2022.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,045 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93M shares
of 105M outstanding shares and own 88.56% of the company stock.
Largest 10 shareholders include FMR LLC (10.2M shares), BlackRock Inc. (9.49M shares), VANGUARD GROUP INC (8.57M shares), Capital World Investors (6.23M shares), JPMORGAN CHASE & CO (5.68M shares), STATE STREET CORP (5.13M shares), WELLINGTON MANAGEMENT GROUP LLP (2.38M shares), Dodge & Cox (2.27M shares), GEODE CAPITAL MANAGEMENT, LLC (2.21M shares), and Capital International Investors (1.79M shares).
This table shows the top 1045 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.